Le Lézard
Classified in: Health
Subjects: NPT, PDT, WOM

BLUE CROSS BLUE SHIELD OF MASSACHUSETTS PRIORITIZES WOMEN'S HEALTH WITH NEW CLINICAL TEAM AND EXPANDED CARE OPTIONS


State's leading health plan launches new solutions to support women and families through fertility, maternity, menopause, and more

BOSTON, Feb. 5, 2024 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ("Blue Cross") today announced a new suite of offerings, including a new clinical team and expanded care options, to ensure that women have access to the high-quality care and resources they need to feel supported throughout their life.

"Far too often, women struggle to get the right care ? whether it's trying to have a family, needing postpartum support, or managing menopause symptoms," said Sarah Iselin, Blue Cross' president and CEO. "This new approach will ensure we can show up for our members at all of these critical moments with the care and support they need and deserve."

NEW REPRODUCTIVE HEALTH CARE TEAM
Blue Cross' new Reproductive Health Care team gives Blue Cross members access to personalized support options and resources for a variety of women's health issues, including supporting diverse families embarking on their parenthood journey. The multidisciplinary support team is led by an OB/GYN physician, and includes other women's health clinicians dedicated to helping members find the right care, including:

NEW SUITE OF CARE OPTIONS WITH 24/7 SUPPORT
Blue Cross is also partnering with Maven Clinic, the world's largest virtual clinic for women and families, which offers 24/7 video appointments and virtual support throughout the reproductive health journey. Maven's Maternity Foundation program is available at no cost to Blue Cross fully-insured 51+ accounts. The program is also available as an optional service for self-insured accounts, in addition to other Maven programs for Blue Cross employer customers.

Maven providers, spanning 30+ specialties and speaking 35+ languages, work with members navigating various journeys, from fertility and family building to maternity, parenting, pediatrics, and menopause. Through its different programs, members will have access to robust support and services, including: 

"Blue Cross Blue Shield of Massachusetts is doing the essential work of reimagining women's healthcare for its members," said Dr. Neel Shah, Chief Medical Officer of Maven Clinic. "We are excited to collaborate closely with their new Reproductive Health Care team on these efforts, ensuring families across the state can access holistic, personalized, and clinically-proven care for every journey." 

"Our employer customers told us they want new ways to support their employees with specific challenges related to women's health, including fertility and menopause," said Dr. Sandhya Rao, Blue Cross' chief medical officer. "Partnering with Maven helps us build out our offerings to ensure that our members feel supported and empowered to take charge of their health. It was important to us to find a partner like Maven who can offer 24/7 virtual support for a comprehensive member experience that meets women's needs."

Blue Cross plans to offer Maven services to its employees in the coming months.

Additional reproductive health and women's health services and resources include reimbursement for childbirth classes, breast pump savings, lactation counseling and more. Members can visit MyBlue to learn more about what is available to them.

About Blue Cross Blue Shield of Massachusetts
Blue Cross Blue Shield of Massachusetts (bluecrossma.org) is a community-focused, tax-paying, not-for-profit health plan headquartered in Boston. We are committed to showing up for everyone like they're the only one and guiding our members to the exceptional health care they deserve ? affordably, equitably and seamlessly. In keeping with our commitment, we are rated among the nation's best health plans for member satisfaction and quality. Connect with us on FacebookTwitterYouTube, and LinkedIn.

SOURCE Blue Cross Blue Shield of Massachusetts


These press releases may also interest you

at 09:15
The "Infectious Diseases Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Diseases Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access...

at 09:05
GE HealthCare today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor that can provide clinicians with an accurate view of patient vital signs to support...

at 09:05
Merck , known as MSD outside of the United States and Canada, today announced results from STRIDE-10, a Phase 3 trial evaluating V116, the company's investigational, adult-specific 21-valent pneumococcal conjugate vaccine, at the 34th European...

at 09:00
? 2023 marked by Ceapro's achievement of key milestones and progress toward its next phase of growth ? R&D activities focused on advancement of avenanthramide Phase 1-2a clinical study and the processing of yeast beta glucan along with the...

at 09:00
Deloitte announced that it has acquired substantially all of the assets of Gryphon Scientific, LLC (Gryphon), a leader in biosafety, biosecurity, and all-hazards preparedness and response, with experience in using artificial intelligence (AI) to...

at 09:00
Imagenet, LLC, a leading healthcare operations partner, announced their acceptance as a Preferred Vendor for the Association for Community Affiliated Plans (ACAP). ACAP represents 79 health plans that collectively serve more than 25 million covered...



News published on and distributed by: